BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4725926)

  • 1. Potential psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene analogs.
    Barfknecht CF; Nichols DE; Rusterholz DB; Long JP; Engelbrecht JA; Beaton JM; Bradley RJ; Dyer DC
    J Med Chem; 1973 Jul; 16(7):804-8. PubMed ID: 4725926
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
    Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
    J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity relationships in psychotomimetic phenylalkylamines.
    Aldous FA; Barrass BC; Brewster K; Buxton DA; Green DM; Pinder RM; Rich P; Skeels M; Tutt KJ
    J Med Chem; 1974 Oct; 17(10):1100-11. PubMed ID: 4418757
    [No Abstract]   [Full Text] [Related]  

  • 4. Contractile responses of guinea pig umbilical arteries to various hallucinogenic agents.
    Nair X
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):535-42. PubMed ID: 4445570
    [No Abstract]   [Full Text] [Related]  

  • 5. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
    Tonge SR; Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
    [No Abstract]   [Full Text] [Related]  

  • 6. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 7. A conformational study of phenethylamine receptor sites. 2. Synthesis of dl-2-amino-3-phenyl-trans-decalins and dl-2-isopropylamino-3-phenyl-trans-decalins.
    Smissman EE; Pazdernik TL
    J Med Chem; 1973 Jan; 16(1):18-23. PubMed ID: 4682194
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure activity relations of some indolealkylamines in comparison to phenethylamines on motor activity and acquisition of avoidance behavior.
    Vasko MR; Lutz MP; Domino EF
    Psychopharmacologia; 1974 Mar; 36(1):49-58. PubMed ID: 4525044
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrographic and behavioral effects of various hallucinogens in the free cat].
    Rougeul A; Verdeaux J; Letalle A
    Rev Neurol (Paris); 1969 Jun; 120(6):391-4. PubMed ID: 5379317
    [No Abstract]   [Full Text] [Related]  

  • 10. Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
    Glennon RA; Rosecrans JA
    Neurosci Biobehav Rev; 1982; 6(4):489-97. PubMed ID: 6757811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of hallucinogens at the clinical level.
    Wyatt RJ; Cannon EH; Stoff DM; Gillin JC
    Ann N Y Acad Sci; 1976; 281():456-86. PubMed ID: 828469
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
    Cheng HC; Long JP; Nichols DE; Barfknecht CF
    J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-activity-relationships of certain hallucinogenic substances based on brain levels.
    Vogel WH; Evans BD
    Life Sci; 1977 May; 20(10):1629-35. PubMed ID: 69244
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Candyflipping': synergistic discriminative effect of LSD and MDMA.
    Schechter MD
    Eur J Pharmacol; 1998 Jan; 341(2-3):131-4. PubMed ID: 9543229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrine and its derivatives antagonize cholinergic psychotomimetics. Behavioural study in rats.
    Koupilová M; Fusek J; Hrdina V
    Act Nerv Super (Praha); 1978 Feb; 20(1):76-7. PubMed ID: 636787
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
    Appel JB; Cunningham KA
    Psychopharmacol Bull; 1986; 22(3):959-67. PubMed ID: 3797596
    [No Abstract]   [Full Text] [Related]  

  • 18. Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities.
    Glennon RA; Liebowitz SM; Leming-Doot D; Rosecrans JA
    J Med Chem; 1980 Sep; 23(9):990-4. PubMed ID: 7411554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD.
    Knoll J; Vizi ES; Knoll B
    Acta Physiol Acad Sci Hung; 1970; 37(1):151-70. PubMed ID: 5433553
    [No Abstract]   [Full Text] [Related]  

  • 20. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.